{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:03:31Z","timestamp":1756339411481,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,11,15]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>A woman in her 20s presented with ascending weakness and paraesthesia along with flu-like symptoms. Neurological examination revealed right facial numbness along V2 distribution and flaccidity in her lower extremities, with a motor power of 0\/5 throughout. The T4 sensory level and bilaterally positive Babinski sign were noted. Brain MRI revealed multiple bilateral T2\/fluid attenuated inversion recovery hyperintense lesions with central enhancement involving the right trigeminal nerve. Full spine MRI demonstrated long-segment thoracic cord demyelination extending from T1 to T11 and nerve root enhancement. An extensive workup for infectious and autoimmune aetiologies was conducted, which revealed a positive COVID-19 result. The patient was diagnosed with encephalomyeloradiculitis secondary to COVID-19 infection. Encephalomyeloradiculitis is a rare neurological condition associated with various underlying conditions. Understanding the causes and differentiating these conditions is essential for appropriate treatment.<\/jats:p>","DOI":"10.1136\/bcr-2023-257672","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:38:11Z","timestamp":1701088691000},"page":"e257672","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Encephalomyeloradiculitis after COVID-19 infection"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-664X","authenticated-orcid":false,"given":"Yoji","family":"Hoshina","sequence":"first","affiliation":[{"name":"Neurology, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Radiology, Chiba University, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"2025082701514338000_16.11.e257672.1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025082701514338000_16.11.e257672.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30221-0"},{"key":"2025082701514338000_16.11.e257672.3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa240"},{"key":"2025082701514338000_16.11.e257672.4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00701-020-04374-x","article-title":"SARS-Cov-2 can induce brain and spine demyelinating lesions","volume":"162","author":"Zanin","year":"2020","journal-title":"Acta Neurochir (Wien)"},{"key":"2025082701514338000_16.11.e257672.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.062"},{"key":"2025082701514338000_16.11.e257672.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"2025082701514338000_16.11.e257672.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"2025082701514338000_16.11.e257672.8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1352458520949988","article-title":"COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: cause or coincidence","volume":"27","author":"Corr\u00eaa","year":"2021","journal-title":"Mult Scler"},{"key":"2025082701514338000_16.11.e257672.9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2025082701514338000_16.11.e257672.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323667"},{"key":"2025082701514338000_16.11.e257672.11","doi-asserted-by":"publisher","DOI":"10.1086\/339811"},{"key":"2025082701514338000_16.11.e257672.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0719-z"},{"key":"2025082701514338000_16.11.e257672.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101506","article-title":"A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous IVMP and PLEX","volume":"38","author":"Songthammawat","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-257672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:52:06Z","timestamp":1756284726000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-257672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":13,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,27]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bcr-2023-257672"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-257672","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}